Other
Knee Replacement Surgery
0
Pipeline Programs↗
2
Active Trials↗
6
Companies Involved↗
Knee Replacement Surgery is an early-stage landscape with 0 programs across 6 companies. The most active players are Bristol-Myers Squibb, Johnson & Johnson, Eli Lilly.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
30
clinical trials
Completed24 · 80%
Terminated3 · 10%
Not yet recruiting1 · 3%
Unknown status1 · 3%
Recruiting1 · 3%
Clinical Trials
Trial Activity
30 trials
Comparing Femoral Nerve Catheters to Single Shot Femoral Nerve Blocks for Total Knee Replacement Surgery
Completed·—·N/A·NCT02106481·99 enrolled
Local Injection of Local Anesthetic 24 Hours After Knee Replacement Surgery May Decrease Pain for Several More Hours
Completed·—·N/A·NCT02420951·50 enrolled
Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098)
Completed·—·Phase 3·NCT00820027·776 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)